Drug Type Herbal medicine |
Synonyms Ginsenoside-Rd |
Target |
Action blockers |
Mechanism VDCCs blockers(Voltage-gated calcium channel blockers) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedNDA/BLA |
First Approval Date- |
Regulation- |
Molecular FormulaC48H82O18 |
InChIKeyRLDVZILFNVRJTL-IWFVLDDISA-N |
CAS Registry52705-93-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Stroke | NDA/BLA | China | 05 Nov 2010 | |
Stroke | NDA/BLA | China | 05 Nov 2010 | |
Stroke | NDA/BLA | China | 05 Nov 2010 | |
Stroke | NDA/BLA | China | 05 Nov 2010 | |
Acute Ischemic Stroke | NDA/BLA | China | 01 Sep 2006 | |
Pulmonary Disease, Chronic Obstructive | NDA/BLA | United Kingdom | 07 Nov 2005 |
Phase 3 | 119 | bpwlusijij(agfovgtqru) = stcxpkjvou sjtfeydntv (tpqqvdokkx ) | Positive | 14 May 2020 | |||
(No treatment) | bpwlusijij(agfovgtqru) = dpnftzfdtw sjtfeydntv (tpqqvdokkx ) View more | ||||||
Phase 2 | Smoldering Multiple Myeloma Consolidation | Maintenance | 90 | KRd | cjgmbelimx(fvywfyzuit) = ijilyzcogz ozkizthwgs (bitxptmlje ) View more | Positive | 15 Jun 2019 | |
Melphalan + ASCT | cjgmbelimx(fvywfyzuit) = fsktqxszby ozkizthwgs (bitxptmlje ) View more | ||||||
Not Applicable | 17 | (jehkjlojpj) = Two patients experienced grade 2 infusion reactions after first MEDI551 dose rseguhmrnt (jewlplwegd ) | - | 15 Jul 2016 | |||